Chelating drug-induced labile Zn2+ with nanoparticle-encapsulated TPEN at low dose enhances lung cancer chemotherapy through inhibiting ABCB1
Authors:
Open Access
- 4 October 2024
- Vol. 27 (11) , 111072
Abstract
No abstract availableKeywords
Funding Information
- Health Commission of Henan Province (YQRC2023005)
- Health Commission of Henan Province (SBGJ202302037)
- National Natural Science Foundation of China (82073231)
- National Natural Science Foundation of China (32370973)
- National Natural Science Foundation of China (82372911)
- Science and Technology Department, Henan Province (232102311050)
This publication has 56 references indexed in Scilit:
- Zinc availability regulates exit from meiosis in maturing mammalian oocytesNature Chemical Biology, 2010
- Zinc, metallothioneins and immunosenescenceProceedings of the Nutrition Society, 2010
- ZIP7-Mediated Intracellular Zinc Transport Contributes to Aberrant Growth Factor Signaling in Antihormone-Resistant Breast Cancer CellsEndocrinology, 2008
- Zinc binding ligands and cellular zinc trafficking: Apo-metallothionein, glutathione, TPEN, proteomic zinc, and Zn-Sp1Journal of Inorganic Biochemistry, 2008
- Cellular stress and intracellular zinc dyshomeostasisArchives of Biochemistry and Biophysics, 2007
- Zinc regulates the ability of Cdc25C to activate MPF/cdk1Journal of Cellular Physiology, 2007
- Zinc-buffering capacity of a eukaryotic cell at physiological pZnJBIC Journal of Biological Inorganic Chemistry, 2006
- Flow cytometric measurement of labile zinc in peripheral blood mononuclear cellsAnalytical Biochemistry, 2006
- Zinc Release from Protein Kinase C as the Common Event during Activation by Lipid Second Messenger or Reactive OxygenJournal of Biological Chemistry, 2002
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group.1995